RA Messages for June 11, 2002


 PHARMACY PROVIDERS, PLEASE NOTE!!!

IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG PRODUCT, PLEASE CONTACT THE PBM HELP DESK AT 1-800-648-0790.

PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION 0F APPENDIX A:

DRUG  DOSAGE STRGTH MAC  EFF. DATE
PROMETHAZINE HCL TABLET 25MG OFF MAC 06/01/02 
PROMETHAZINE HCL TABLET 50MG  OFF MAC 06/01/02 

PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION 0F APPENDIX B: 

NDC  TRADENAME    DOSAGE
00591-4007-01 CLIDINIUM BR/CHLORDIAZEPOXIDE  CAPSULE 
00591-4007-05  CLIDINIUM BR/CHLORDIAZEPOXIDE  CAPSULE
00603-1636-58 GUAIFENESIN/PHENYLEPHRINE/HCOD   SYRUP
47028-0057-16 GUAIFEN/KG/DM/P-EPHEDRINE/CP LIQUID 

PLEASE MAKE THE FOLLOWING CHANGES TO THE 1/1/02 VERSION 0F APPENDIX C:

LABELER  COMPANY  BEGIN  END 
21200 3M PHARMACEUTICALS     7/1/02 
51131 3M PHARMACEUTICALS    7/1/02 
64054 EMT-RX  7/1/02   
65005 PTS LABS   7/1/02 
66825 BIOCODEX INCORPORATED 7/1/02    
66869  PROETHIC LABORATORIES 7/1/02    

  PLEASE FILE ADJUSTMENTS FOR CLAIMS WHICH MAY HAVE BEEN INCORRECTLY PAID.


NOTICE TO COMMUNITYCARE PROVIDERS

THIS IS TO REMIND ALL COMMUNITYCARE PCPS THAT PAYMENT OF COMMUNITYCARE MANAGEMENT FEES IS MADE AFTER THE SIGNATURE SHEET FROM THE MONTHLY CP-O-92 IS SUBMITTED TO UNISYS FOR PAYMENT AT THE END OF THE MONTH. THE RULES FOR TIMELY FILING APPLY TO THESE MANAGEMENT FEES AS THEY DO TO ALLCLAIMS, IN THAT THEY MUST BE FILED WITHIN ONE YEAR FROM THE DATE OF SERVICE, WHICH IS THE FIRST DAY OF THE MONTH. PROVIDERS SHOULD, THEREFORE, SUBMIT SIGNATURE SHEETS AND CONFIRM RECEIPT OF PAYMENT FOR EACH MONTH IN A TIMELY MANNER, IN ORDER TO AVOID DENIALS BECAUSE OF 
FAILURE TO FILE TIMELY. 

AN ADDITIONAL REMINDER - PROVIDER SHOULD KEEP A COPY OF EACH SIGNATURE 
PAGE WITHOUT THE SIGNATURE. IF PAYMENT IS NOT RECEIVED FOR ANY MONTH, 
AN ORIGINAL SIGNATURE CAN BE PLACED ON THE COPY OF THE SIGNATURE SHEET, 
AND IT CAN BE RESUBMITTED TO UNISYS FOR PAYMENT. 

QUESTIONS REGARDING THIS MATTER MAY BE DIRECTED TO UNISYS PROVIDER 
RELATIONS AT 1-800-473-2783.